Brain biomechanics group
The Brain biomechanics group combines advanced neuroimaging, computational modelling and artificial intelligence to investigate how the brain responds to injury and disease. We develop personalised digital twins that integrate MRI and sensor data to quantify brain structure and mechanical behaviour. Our long-term goal is to support more objective diagnosis, prognosis and personalised rehabilitation for concussion and neurodegenerative disease.
Brain concussion research
Since 2021, the ABI and Mātai Medical Research Institute have conducted a longitudinal study of adolescent rugby players in Aotearoa, New Zealand. Players undergo repeated MRI scans across the rugby season, while instrumented mouthguards record the frequency and magnitude of head impacts. By combining neuroimaging, head-impact kinematics, clinical assessments and subject-specific computational models, we investigate how repetitive head impacts and concussion affect the brain over time. Our goal is to develop objective methods for assessing injury severity and predicting recovery.
Brain tissue mechanics research
Brain tissue changes often precede any visible changes in neurological diseases such as brain injury and neurodegenerative diseases. We aim to characterise this subtle change with a novel AI-based technique that combines advanced MRI and digital twin modelling. Specifically, our method can characterise brain tissue properties to characterise early changes in brain tissue before any visible signs appear. We aim to use this as an early diagnosis tool for neurodegenerative diseases.
Wearable sensor-based detection and monitoring of brain changes
Because MRI is not readily accessible for routine monitoring, we aim to develop an MRI-free surrogate model that can provide an indication of brain health from wearable sensor data. Using large datasets such as the UK Biobank, which include both MRI and wrist-worn activity data, we are training our digital-twin-based AI model to predict indicators of brain health from wearable measurements. Depending on the application, these may include physiological measures such as heart-rate variability or head-impact signals. The aim of this project is to develop a wearable-sensor-based diagnostic and prognostic tool that may identify warning signs earlier than conventional testing methods.
Members
Primary contact
Academics
Vickie Shim
Eryn Kwon
Maryam Tayebi
Samantha Holdsworth
Justin Fernandez
Alan Wang
Students
Christian Saludar
Jacob Mathew
Katze Zambo
Chun Vong
Maerdian Adili
Lu Cheng
Rohan Dhuri
Collaborators
Prof. Antoine Jerusalem (Oxford, UK)
Prof. Mehmet Kurt (University of Washington, Seattle, USA)
Dr. Lucy Hiscox (Cardiff University, UK)
Prof . Yun Jung Bae (SNU, South Korea)
Prof.. Silvia Budday (Friedirch-Alexander-Universitat)
Prof. Benedicte Vanwanseele (KU Leuven)
Funding
Marsden
Neurological Foundation
HRC
TTM RAP Funding
Royal Society of NZ Catalyst